Abstract:Ubiquitination and deubiquitination are important forms of posttranslational modification that govern protein homeostasis. Deubiquitinating enzymes (DUBs), a protein superfamily consisting of more than 100 members, deconjugate ubiquitin chains from client proteins to regulate cellular homeostasis. However, the dysregulation of DUBs is reportedly associated with several diseases, including cancer. The tumor microenvironment (TME) is a highly complex entity comprising diverse noncancerous cells (e.g., immune cells and stromal cells) and the extracellular matrix (ECM). Since TME heterogeneity is closely related to tumorigenesis and immune evasion, targeting TME components has recently been considered an attractive therapeutic strategy for restoring antitumor immunity. Emerging studies have revealed the involvement of DUBs in immune modulation within the TME, including the regulation of immune checkpoints and immunocyte infiltration and function, which renders DUBs promising for potent cancer immunotherapy. Nevertheless, the roles of DUBs in the crosstalk between tumors and their surrounding components have not been comprehensively reviewed. In this review, we discuss the involvement of DUBs in the dynamic interplay between tumors, immune cells, and stromal cells and illustrate how dysregulated DUBs facilitate immune evasion and promote tumor progression. We also summarize potential small molecules that target DUBs to alleviate immunosuppression and suppress tumorigenesis. Finally, we discuss the prospects and challenges regarding the targeting of DUBs in cancer immunotherapeutics and several urgent problems that warrant further investigation.

The Role of Deubiquitinases in Oncovirus and Host Interactions

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities

Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity

Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

Deubiquitylating Enzymes in Cancer and Immunity

Viral deubiquitinases and innate antiviral immune response in livestock and poultry

Fine-tuning of antiviral innate immunity by ubiquitination

Human DUBs' Gene Expression and Regulation in Antiviral Signaling in Response to Poly (I:C) Treatment.

Regulation of cellular innate antiviral signaling by ubiquitin modification.

The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses

Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection

The emerging role and therapeutic implications of bacterial and parasitic deubiquitinating enzymes

Modulation of Ubiquitin Signaling in Innate Immune Response by Herpesviruses

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion

Viral deubiquitinating proteases and the promising strategies of their inhibition

Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention Strategies

Role of SUMOylation in Human Oncogenic Herpesvirus Infection

Dual-Role Ubiquitination Regulation Shuttling the Entire Life Cycle of the Flaviviridae